About SMSBIOTECH, INC.
SMSbiotech is a clinical-stage regenerative medicine company developing a first-in-class Small Mobile Stem (SMS) cell therapy platform. It is focused on advancing its lead COPD program through clinical development and expanding into Phase 2 studies.
Developing a first-in-class Small Mobile Stem (SMS) cell therapy platformManufacturing cells for therapeutic use at an industrial scaleClinical-stage biomanufacturing capabilities including ISO-7 clean room infrastructureAdvancing a lead COPD program through Phase 1b clinical development
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to SMSBIOTECH, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.